I’m considering dipping my toes in at the current share price, but the prospect of another dividend cut feels imminent. The stock has been beat down the past 6 months, and it begs the question whether or not their leadership is competent enough to right the ship in a digital age where only more pharmaceutical competition is springing up-namely online. Is this yield too good to be true, or do you perceive buying now as catching the falling knife?
Update: I am holding off on snagging shares for now. A significant amount of comments recommended alternative pharmaceutical companies, and I had no idea that Walmart’s pharmacy was performing as well as it is (have shares of it). Thank you for your time!
Leave a Reply